Smoking Behavior Clinical Trial
Official title:
Smoking Research With Incarcerated Females
Verified date | September 2018 |
Source | University of Alabama at Birmingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this study is to understand the smoking behavior of female incarcerated smokers and to determine how smokers differ from non-smokers on measures of substance abuse, personality, criminal history, and mental illness
Status | Completed |
Enrollment | 360 |
Est. completion date | March 2008 |
Est. primary completion date | March 2008 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years to 100 Years |
Eligibility |
Inclusion Criteria: - all smokers, non-smokers, and ex-smokers Exclusion Criteria: - inability to understand English and inability to be able to provide informed consent due to mental impairment |
Country | Name | City | State |
---|---|---|---|
United States | Virginia Commonwealth University | Richmond | Virginia |
Lead Sponsor | Collaborator |
---|---|
University of Alabama at Birmingham | National Cancer Institute (NCI), National Institute on Drug Abuse (NIDA) |
United States,
Cropsey K, Eldridge GD, Ladner T. Smoking among female prisoners: an ignored public health epidemic. Addict Behav. 2004 Feb;29(2):425-31. — View Citation
Cropsey KL, Kristeller JL. Motivational factors related to quitting smoking among prisoners during a smoking ban. Addict Behav. 2003 Aug;28(6):1081-93. — View Citation
Cropsey KL, Kristeller JL. The effects of a prison smoking ban on smoking behavior and withdrawal symptoms. Addict Behav. 2005 Mar;30(3):589-94. — View Citation
Haller DL, Miles DR, Cropsey KL. Smoking stage of change is associated with retention in a smoke-free residential drug treatment program for women. Addict Behav. 2004 Aug;29(6):1265-70. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00995033 -
Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)
|
Phase 2 | |
Completed |
NCT01635075 -
Acute Effects of Exercise in Smokers With Schizophrenia
|
Phase 2 | |
Completed |
NCT03498053 -
Smoking Topography Study 2018
|
N/A |